{"id":"NCT03320018","sponsor":"Stony Brook University","briefTitle":"Neuroprotection in Acute Ischemic Stroke","officialTitle":"Pilot Study of the Neuroprotective Effects of Hydrogen and Minocycline in Acute Ischemic Stroke","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2017-08-02","primaryCompletion":"2019-08-13","completion":"2019-08-13","firstPosted":"2017-10-24","resultsPosted":"2023-12-19","lastUpdate":"2023-12-19"},"enrollment":15,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Stroke, Ischemic"],"interventions":[{"type":"DRUG","name":"Hydrogen","otherNames":["H2"]},{"type":"DRUG","name":"Minocycline","otherNames":["Minocin","Minomycin","Akamin"]},{"type":"OTHER","name":"Placebo Hydrogen","otherNames":[]},{"type":"OTHER","name":"Placebo Minocycline","otherNames":[]}],"arms":[{"label":"Hydrogen/Minocycline","type":"EXPERIMENTAL"},{"label":"Placebo Hydrogen/Placebo Minocycline","type":"PLACEBO_COMPARATOR"}],"summary":"This is a pilot randomized control trial (RCT) to explore the possible beneficial effect of a novel combination therapy consisting of molecular hydrogen H2 plus minocycline (\"H2M\"), on neurological recovery after acute ischemic stroke.","primaryOutcome":{"measure":"Number of Participants With Favorable Outcome on the Simplified Modified Rankin Scale (sMRSq)","timeFrame":"90 days","effectByArm":[{"arm":"Hydrogen/Minocycline","deltaMin":5,"sd":null},{"arm":"Placebo Hydrogen/Placebo Minocycline","deltaMin":7,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":6},"commonTop":["rash","hypotension","headache","Hypotension","urinary tract infection"]}}